Section Arrow
CING.NASDAQ
- Cingulate Inc
Quotes are at least 15-min delayed:2026/04/07 10:32 EDT
Regular Hours
Last
 5.875
-0.325 (-5.24%)
Day High 
6.14 
Prev. Close
6.2 
1-M High
11.89 
Volume 
91.00K 
Bid
5.88
Ask
5.92
Day Low
5.8001 
Open
6.14 
1-M Low
5.63 
Market Cap 
46.17M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 6.31 
20-SMA 7.47 
50-SMA 6.74 
52-W High 11.89 
52-W Low 3.2 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.44/-1.06
Enterprise Value
48.42M
Balance Sheet
Book Value Per Share
0.22
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
LNAILunai Bioworks Inc.0.3851+0.1031+36.56%-- 
SILOSilo Pharma0.4837+0.1279+35.95%-- 
TERNTerns Pharmaceuticals52.61-0.17-0.32%-- 
CUECue Biopharma0.1804+0.0034+1.92%-- 
QNCXQuince Therapeutics0.0963+0.0088+10.06%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Cingulate Inc is a clinical-stage biopharmaceutical company focused on the development of products utilizing its drug delivery platform technology that enables the formulation and manufacture of once-daily tablets of multi-dose therapies, with an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety. The Company is developing two proprietary, first-line stimulant medications, CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine), for the treatment of ADHD intended for all patient segments: children, adolescents, and adults. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.